MXPA02012301A - Separacion entre enantiomeros de derivados de piperidona con simultanea racemizacion in situ del enantiomero indeseado. - Google Patents

Separacion entre enantiomeros de derivados de piperidona con simultanea racemizacion in situ del enantiomero indeseado.

Info

Publication number
MXPA02012301A
MXPA02012301A MXPA02012301A MXPA02012301A MXPA02012301A MX PA02012301 A MXPA02012301 A MX PA02012301A MX PA02012301 A MXPA02012301 A MX PA02012301A MX PA02012301 A MXPA02012301 A MX PA02012301A MX PA02012301 A MXPA02012301 A MX PA02012301A
Authority
MX
Mexico
Prior art keywords
simultaneous
situ
enantiomer separation
piperidone derivatives
enantiomer
Prior art date
Application number
MXPA02012301A
Other languages
English (en)
Inventor
Hermann Mueller-Boetticher
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA02012301A publication Critical patent/MXPA02012301A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

El invento se refiere a un procedimiento aplicable a escala tecnica para la separacion dinamica entre enantiomeros de derivados de piperidona con la formula general (1); (ver formula) en la que R1, R2, R3 y n pueden tener los significados mencionados en la memoria descriptiva y en las reivindicaciones, con racemizacion simultanea in situ del enantiomero que no haya reaccionado.
MXPA02012301A 2000-06-16 2001-06-09 Separacion entre enantiomeros de derivados de piperidona con simultanea racemizacion in situ del enantiomero indeseado. MXPA02012301A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10029851A DE10029851A1 (de) 2000-06-16 2000-06-16 Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
PCT/EP2001/006552 WO2001096306A1 (de) 2000-06-16 2001-06-09 Enantiomerentrennung von piperidon-derivaten unter gleichzeitiger in situ racemisierung des unerwünschten enantiomers

Publications (1)

Publication Number Publication Date
MXPA02012301A true MXPA02012301A (es) 2003-04-25

Family

ID=7646064

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012301A MXPA02012301A (es) 2000-06-16 2001-06-09 Separacion entre enantiomeros de derivados de piperidona con simultanea racemizacion in situ del enantiomero indeseado.

Country Status (10)

Country Link
EP (1) EP1305287A1 (es)
JP (1) JP2004503539A (es)
KR (1) KR100863922B1 (es)
AR (1) AR028957A1 (es)
AU (1) AU2001270563A1 (es)
CA (1) CA2409614C (es)
DE (1) DE10029851A1 (es)
IL (2) IL153085A0 (es)
MX (1) MXPA02012301A (es)
WO (1) WO2001096306A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0736724B2 (ja) * 1992-08-07 1995-04-26 株式会社スリオンテック 紫外線硬化型粘着剤を用いた播種育苗シート及びその製造方法
PT782569E (pt) * 1994-09-23 2002-09-30 Darwin Discovery Ltd Processo de racemizacao utilizado no fabrico de levobupivacaina e seus analogos
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan

Also Published As

Publication number Publication date
DE10029851A1 (de) 2001-12-20
JP2004503539A (ja) 2004-02-05
IL153085A (en) 2008-11-26
KR100863922B1 (ko) 2008-10-17
KR20030016288A (ko) 2003-02-26
IL153085A0 (en) 2003-06-24
CA2409614C (en) 2008-08-05
CA2409614A1 (en) 2001-12-20
EP1305287A1 (de) 2003-05-02
AU2001270563A1 (en) 2001-12-24
AR028957A1 (es) 2003-05-28
WO2001096306A1 (de) 2001-12-20

Similar Documents

Publication Publication Date Title
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
MY128639A (en) 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
IL147803A0 (en) 28-epirapalogs
WO2002072865A3 (en) Methods, kits and compositions of combination oligomers
AU5996201A (en) Microphysiometer
TW200502029A (en) Composition and process
HUP0303034A3 (en) Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
IL163896A0 (en) Piperidine or 8-aza-bicycloÄ3.2.1Üoct-3-yl derivatives useful as modulators of chemokine receptoractivity (especially ccr5)
AU2003282039A1 (en) Method for fastening a tool within a tool chuck
BG104291A (en) 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
BG104034A (en) Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect
GR20010100601A (el) Προτυπα αναφορας για τον προσδιορισμο της καθαροτητας ή σταθεροτητας της μιλεινικης αμλοδιπινης και διεργασιες για αυτα.
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
WO1999037291A3 (de) Verwendung von substituierten sulfonamiden als antivirale mittel und neue stoffe
MXPA02011558A (es) Inhibidores de mmp-2/mp-9 novedosos.
ATE302301T1 (de) Trägerloses linoleum-flächengebilde und verfahren zu dessen herstellung
MXPA02012301A (es) Separacion entre enantiomeros de derivados de piperidona con simultanea racemizacion in situ del enantiomero indeseado.
WO2001038292A3 (de) Verfahren zur herstellung optisch aktiver amine
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
SE9801366D0 (sv) Genomfärgade träelement samt sätt att framställa genomfärgade träelement
ATA8299A (de) Plattenförmiges presswerkzeug und verfahren zu dessen herstellung
NZ514573A (en) Beta-hydroxyalkylamides, process for their production and their use
CZ20022240A3 (cs) Mannichovy báze substituovaného 1-a 2-naftolu
AU2002226308A1 (en) Method for producing dnda
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration